Xtant Medical Holdings Inc (XTNT)

0.3951 -0.02 (-4.73%) USD  |  NYAM  |  Nov 22, 16:00
0.40 0.00 (0.00%) After-Hours: 20:00
More

Xtant Medical Holdings Research and Development Expense (Quarterly): 0.701M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
September 30, 2024 0.701M
June 30, 2024 0.636M
March 31, 2024 0.527M
December 31, 2023 0.492M
September 30, 2023 0.49M
June 30, 2023 0.18M
March 31, 2023 0.174M
December 31, 2022 0.232M
September 30, 2022 0.229M
June 30, 2022 0.241M
March 31, 2022 0.213M
December 31, 2021 0.151M
September 30, 2021 0.262M
June 30, 2021 0.243M
March 31, 2021 0.214M
December 31, 2020 0.128M
September 30, 2020 0.176M
June 30, 2020 0.111M
March 31, 2020 0.245M
December 31, 2019 0.257M
September 30, 2019 0.203M
June 30, 2019 0.21M
March 31, 2019 0.262M
December 31, 2018 0.523M
Date Value
September 30, 2018 0.347M
June 30, 2018 0.418M
March 31, 2018 0.414M
December 31, 2017 0.598M
September 30, 2017 0.504M
June 30, 2017 0.64M
March 31, 2017 0.699M
December 31, 2016 0.7982M
September 30, 2016 0.9289M
June 30, 2016 0.7839M
March 31, 2016 0.8996M
December 31, 2015 1.027M
September 30, 2015 0.7945M
June 30, 2015 0.2912M
March 31, 2015 0.4336M
December 31, 2014 0.4879M
September 30, 2014 0.3783M
June 30, 2014 0.3223M
March 31, 2014 0.2546M
December 31, 2013 0.3476M
September 30, 2013 0.0377M
June 30, 2013 0.1698M
March 31, 2013 0.2851M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

0.111M
Minimum
Jun 2020
0.701M
Maximum
Sep 2024
0.2951M
Average
0.2365M
Median

Research and Development Expense (Quarterly) Benchmarks

Plus Therapeutics Inc 2.858M
Perspective Therapeutics Inc 12.03M
Retractable Technologies Inc 0.1747M
InfuSystems Holdings Inc --
Catheter Precision Inc 0.063M